Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium

Eur Urol Focus. 2018 Apr;4(3):435-441. doi: 10.1016/j.euf.2017.01.009. Epub 2017 Feb 9.

Abstract

Background: Microscopic vein invasion (MVI), with local destruction and invasion of the endothelium by tumor, is of controversial predictive value in renal cell carcinoma (RCC).

Objective: To assess the impact of venous extension and wall invasion in RCC on survival.

Design, setting, and participants: Data for 1023 RCC patients with vena cava thrombus treated with radical nephrectomy and complete tumor thrombectomy were collected within a prospectively maintained international consortium (1995-2012).

Outcome measurements and statistical analysis: The Kaplan-Meier method and univariable and multivariable Cox regression analyses were used to assess the impact of MVI on cancer-specific survival (CSS). The main two variables of interest were microscopic renal vein wall invasion (MRVI) and microscopic vena cava wall invasion (MVCI).

Results: MRVI was found in 725 cases (70.9%) and MVCI in 230 (22.5%). Patients with MRVI had larger tumors (p=0.005), longer hospital stay (p<0.001), higher clinical stage 0.039), higher Fuhrman grade (p=0.028), and more frequent fat invasion. Presence of MVCI was associated with larger tumors (p<0.001), longer hospital stay (p<0.001), higher clinical stage (p<0.001), lymph node involvement (p=0.045), higher Fuhrman grade (p<0.001), and higher thrombus level (p<0.001). With median follow-up of 52 mo, overall 5-yr CSS was 57.4%. Multivariable analysis showed that presence of MRVI was an independent factor related to CSS (hazard ratio 2.24, 95% confidence interval 1.24-3.59, p=0.006). The main limitation was the inability to report MVI percentages.

Conclusions: Patients with MRVI experience significantly worse survival outcomes after radical nephrectomy and tumor thrombectomy. Consideration of MRVI at final pathology is appropriate to improve decision-making for risk-adapted follow-up.

Patient summary: The behavior of locally advanced renal cell carcinoma (RCC) depends on clinical and pathologic factors. Analysis revealed that RCC patients with microscopic renal vein wall invasion experience significantly worse cancer-specific survival.

Keywords: Microscopic renal vein invasion; Microscopic vena cava invasion; Renal cell carcinoma; Survival.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Carcinoma, Renal Cell
  • Decision Making
  • Female
  • Humans
  • Kidney / blood supply*
  • Kidney / pathology
  • Kidney Neoplasms / blood supply*
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery
  • Male
  • Middle Aged
  • Neoplasm Invasiveness / pathology
  • Neoplasm Invasiveness / ultrastructure*
  • Neoplastic Processes
  • Nephrectomy / methods
  • Nephrectomy / mortality
  • Predictive Value of Tests
  • Prospective Studies
  • Renal Veins / abnormalities
  • Renal Veins / diagnostic imaging
  • Renal Veins / pathology
  • Renal Veins / ultrastructure*
  • Retrospective Studies
  • Survival Analysis
  • Thrombectomy / methods
  • Thrombectomy / mortality
  • Thrombosis / pathology*
  • Thrombosis / surgery
  • Vena Cava, Inferior / abnormalities
  • Vena Cava, Inferior / diagnostic imaging
  • Vena Cava, Inferior / pathology
  • Vena Cava, Inferior / ultrastructure*